Search the Newsreel

Lifecore Biomedical Inc (LFCR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Lifecore Biomedical Inc (LFCR), listing its major individual shareholders and the proportion of shares they hold. It also breaks down shareholder types, such as hedge funds and investment advisors, and provides institutional shareholding data over several quarters, …

CervoMed Inc (CRVO) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for CervoMed Inc (CRVO), covering operating, investing, and financing activities. It presents financial figures for various quarters and years, allowing users to assess the company's financial soundness and stability. The article also includes …

CytoMed Therapeutics Ltd (GDTC) Institutional Confidence

This article provides an overview of institutional holdings in CytoMed Therapeutics Ltd (GDTC), indicating shareholder activity and changes in shares held by various entities. Key shareholders include Glorious Finance Limited, mDR Limited, and 28 Consultants Ltd, with some showing recent changes in their positions. …

OBIO|Orchestra Biomed Holdings Inc|Price:3.810|Chg%:-0.050

This article provides a comprehensive stock analysis of Orchestra BioMed Holdings Inc (OBIO) from TradingKey, highlighting its relatively healthy fundamentals, good growth potential (1113.12% revenue growth), and fair valuation. Institutional ownership is high, and analysts have a "Buy" rating with a target price of …

Orchestra Biomed Holdings Inc (OBIO) Income Statement

This article provides the quarterly and annual income statements for Orchestra Biomed Holdings Inc (OBIO), detailing various financial metrics such as total revenue, operating expenses, R&D expenses, operating profit, and net income over several fiscal quarters and years. It also includes frequently asked questions …

GDTC|CytoMed Therapeutics Ltd|Price:0.871|Chg%:-0.119

This article provides a detailed financial overview of CytoMed Therapeutics Ltd (GDTC), including its stock performance, key financial indicators, and earnings reports. It presents data from income statements, balance sheets, and cash flow statements, offering insights into the company's revenue, net profit, assets, liabilities, …

CytoMed Therapeutics Ltd (GDTC) Cash Flow

This article provides a detailed overview of CytoMed Therapeutics Ltd's (GDTC) cash flow statements, including operating, investing, and financing activities. It presents quarterly and annual financial data, allowing users to evaluate the company's financial health. The report also defines key cash flow metrics and …

Orchestra Biomed Holdings Inc (OBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Orchestra Biomed Holdings Inc (OBIO) focusing on its dividend and stock split history. It indicates that the company has distributed $0.00 in dividends over the past five years and contains no specific dividend or stock split data. The …

Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Lifecore Biomedical Inc (LFCR)'s dividend and stock split history. It states that the company has distributed $0.00 in dividends over the past 5 years, indicating no recent dividend payouts. The page also presents current stock data for LFCR.

Orchestra BioMed Holdings, Inc. Revenue Breakdown – NASDAQ:OBIO

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) reported a total revenue of $33.48 million USD last year. The primary driver of this revenue was its Medical Device segment, contributing the entirety of the figure, a significant increase from $2.64 million USD in the previous year. …

CervoMed Inc (CRVO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of CervoMed Inc (CRVO) stock performance, focusing on its dividend history and stock split events. It indicates that CervoMed has not distributed dividends in the past five years but lists several merger-related stock splits occurring in August 2023 and …

Advanced Biomed Inc (ADVB) Balance Sheet

This article provides a detailed balance sheet for Advanced Biomed Inc (ADVB), presenting quarterly and annual financial data. It covers key financial metrics like assets, liabilities, and shareholders' equity, allowing users to assess the company's financial health, liquidity, and leverage. The report facilitates fundamental …

SomnoMed Posts Record Half-Year Revenue and 35% EBITDA Lift, But FY26 Verdict Is Still to Come

SomnoMed Co-CEO Steps Down; Fiscal 2026 Revenue Misses Guidance

SomnoMed Director Amrita Singh Blickstead Exits Company After Shareholding Disposal

Advanced Biomed Inc (ADVB) Cash Flow

This article provides a detailed cash flow statement for Advanced Biomed Inc (ADVB), covering quarterly and annual data for operating, investing, and financing activities. It presents financial figures for several fiscal quarters, allowing investors to evaluate the company's financial health and stability. The article …

Advanced Biomed Inc (ADVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Advanced Biomed Inc (ADVB) stock, focusing on its support, resistance, various technical indicators, and moving averages. It presents a breakdown of buy, sell, and neutral signals from indicators like MACD, RSI, and ATR, alongside a strong "Buy" …

Orchestra Biomed Holdings Inc (OBIO) Valuation: PE, PB & Fair Value Analysis

Orchestra Biomed Holdings Inc (OBIO) currently has a valuation score of 7.62, placing it 154th out of 200 companies in the Healthcare Equipment & Supplies industry. Its P/E ratio stands at -3.95, indicating a significant deviation from both its recent high and low. Data …

CytoMed Therapeutics Ltd (GDTC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for CytoMed Therapeutics Ltd (GDTC), indicating a "Strong Buy" analyst rating with a target price of USD 5.00, representing a 143.90% upside. It notes that this rating is based on 0 analysts, and relevant financial forecasting data for …

CRVO Income Statement - CervoMed Inc

This article presents the quarterly income statement for CervoMed Inc (CRVO), detailing financial performance metrics such as revenue, operating expenses, and net income over a long period. It includes year-over-year percentage changes and absolute values for various financial line items. Additionally, the article features …

LFCR|Lifecore Biomedical Inc|Price:4.330|Chg%:-0.100

This article provides a detailed financial summary for Lifecore Biomedical Inc (LFCR), including its recent stock performance, key financial statements like income, balance sheet, and cash flow. It highlights the company's latest earnings report with FY2025 revenue of $75.52M and an EPS of -$0.54, …

ADVB|Advanced Biomed Inc|Price:18.980|Chg%:+2.200

Advanced Biomed Inc. (ADVB) closed at $18.980, up 13.11% on July 24, with a market capitalization of $26.23M. The company focuses on providing assay products and services for cancer patients, utilizing a microfluidic technology platform for early screening, diagnosis, and treatment selection. Technical indicators …

Advanced Biomed Inc (ADVB) Income Statement

PASW|Ping An Biomedical Ord Shs|Price:0.132|Chg%:+0.002

Advanced Biomed Inc. Revenue Breakdown – NASDAQ:ADVB

The article provides a detailed navigation of the financial data available for Advanced Biomed Inc. (NASDAQ:ADVB) on TradingView. It highlights sections for financials, statements, statistics, dividends, earnings, and segment performance. The content is primarily a site map for accessing various financial metrics related to …

Lifecore Biomedical, Inc. Revenue Breakdown – NASDAQ:LFCR

Lifecore Biomedical, Inc. (NASDAQ: LFCR) generated $75.52 million USD in total revenue last year. Its top-performing segment, "Lifecore," contributed $128.87 million USD, an increase from $128.26 million USD in the prior year. The United States was the primary regional contributor, accounting for the same …

CytoMed Therapeutics Ltd (GDTC) Income Statement

This article provides the income statement for CytoMed Therapeutics Ltd (GDTC), detailing quarterly and annual financial performance from FY2020H1 to FY2024H2. It includes data on revenue, operating expenses, R&D expenses, operating profit, net income, and earnings per share. The piece also offers FAQs on …

CytoMed Therapeutics (GDTC) director adds 200,000 shares in July buys

CytoMed Therapeutics director and 10% owner Choo Chee Kong purchased 200,000 ordinary shares in July 2026 through two separate transactions at $1.50 per share. An amended Form 4/A corrected the filing to accurately report these as acquisitions rather than dispositions. These trades were not …

Form 4 CytoMed Therapeutics Ltd For: 24 July By Investing.com

This article from Investing.com is a regulatory filing update, announcing the Form 4 for CytoMed Therapeutics Ltd, dated July 24th. The content is primarily a placeholder for the filing details, with additional trending stock data and market summaries provided by the platform. It does …

CervoMed Inc (CRVO) Institutional Confidence

CervoMed Inc (CRVO) has an institutional shareholding score of 3.00, placing it 192nd out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 14.61%, which is a significant decrease of 67.97% quarter-over-quarter. Key institutional shareholders include Morgan Stanley …

Cytomed director, 10% owner Choo Chee Kong acquires $300,000 in common shares

Cytomed Therapeutics director and 10% owner Choo Chee Kong acquired 200,000 ordinary shares at $1.5 each, totaling $300,000. These transactions increased his direct holding to 630,324 shares. The information was disclosed via the U.S. Securities and Exchange Commission's EDGAR system.

CytoMed Therapeutics (GDTC) insider discloses two ordinary share dispositions

CytoMed Therapeutics director and 10% owner Choo Chee Kong reported two non-derivative dispositions of 100,000 ordinary shares each, priced at $1.50 per share, on July 14 and July 20, 2026. These transactions, totaling 200,000 shares sold, were classified as direct ownership, with no post-transaction …

CervoMed Inc. Revenue Breakdown – NASDAQ:CRVO

CervoMed Inc. (NASDAQ:CRVO) generated $4.01 million USD in revenue last year, primarily from its Clinical and Preclinical Product Candidates segment. This also represents its entire revenue from the United States, indicating a sole geographic focus for its current operations. This revenue figure marks a …

Lifecore Biomedical Inc (LFCR) Institutional Confidence

Lifecore Biomedical Inc (LFCR) has an institutional shareholding score of 7.00, placing it 50th in the Pharmaceuticals industry. Institutional investors hold 81.48% of its shares, an increase of 8.09% quarter-over-quarter. The largest institutional holder is ETHSX, with other significant holders including Wynnefield Capital, Inc. …

12 Health Care Stocks Moving In Friday's Pre-Market Session

This article details the pre-market movements of 12 health care stocks on Friday, categorizing them as gainers or losers. Notable gainers include Advanced Biomed (ADVB) and Akanda (AKAN), while Radiopharm Theranostics (RADX) and Zevra Therapeutics (ZVRA) experienced significant declines. The report provides stock symbols, …

CytoMed Therapeutics' US$1.7m Market Cap Fall Books Insider Losses

Insiders at CytoMed Therapeutics, particularly Executive Chairman Chee Kong Choo, are facing losses after the company's market cap fell by US$1.7 million. Despite a recent 14% stock drop, insiders had previously purchased shares at a higher average price, suggesting a continued belief in the …